Olympus reportedly told U.S. managers not to issue a warning about contaminated scopes

Internal e-mails suggest that Olympus officials based in Japan attempted to hide news of a potential outbreak from U.S.


Internal e-mails suggest that Olympus officials based in Japan attempted to hide information about potentially deadly infections linked to its duodenoscopes, according to an article on the Outpatient Survey website.

After Olympus issued a safety alert about its duodenoscopes to its European customers, U.S. executives asked whether they should also warn their customers. 

The Olympus officials told the U.S. executives that issuing a global alert was "not needed" and said the problems were due to poor reprocessing by the U.S. hospitals.

Despite allegedly knowing since 2012 that design issues made the scopes nearly impossible to clean, Olympus continued blaming hospitals for the infections.

Read the article.

 

 



August 2, 2016


Topic Area: Infection Control


Recent Posts

Better, More Thorough Cleaning Saves Lives

Cleanliness is the first line of defense to protect patients from killer pathogens, but many hospitals refuse to make it a priority.


Encompass Health Opens the Rehabilitation Hospital of Amarillo

The 50-bed inpatient rehabilitation hospital is now accepting patients.


Ground Broken on Sarasota Memorial Hospital-North Port

It is expected to be completed in 2028.


Cost Saving Strategies for Hospital Modernization Projects

Modernization efforts can save healthcare entities money if planned correctly.


Central Jersey Medical Center Reports Ransomware Attack

At this time, there is no evidence that patient information has been misused.


 
 


FREE Newsletter Signup Form

News & Updates | Webcast Alerts
Building Technologies | & More!

 
 
 


All fields are required. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 
 
 
 

Healthcare Facilities Today membership includes free email newsletters from our facility-industry brands.

Facebook   Twitter   LinkedIn   Posts

Copyright © 2023 TradePress. All rights reserved.